Pneumococcal Disease News and Research

RSS
Pneumococcal disease describes a group of illnesses caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterial pathogen, which affects both children and adults, is a major cause of death and illness worldwide. In fact, according to the World Health Organization (WHO), pneumococcal disease is the number one vaccine-preventable cause of death in children younger than 5 years of age worldwide.
Current smoking heralds worse outcomes in pneumococcal CAP

Current smoking heralds worse outcomes in pneumococcal CAP

Hypervirulent S. pneumoniae mutants discovered

Hypervirulent S. pneumoniae mutants discovered

Invasive pneumococcal disease in Taiwan on the wane, but threats remain

Invasive pneumococcal disease in Taiwan on the wane, but threats remain

Walgreens collaborates with NMAC to improve treatment outcomes for African Americans with HIV

Walgreens collaborates with NMAC to improve treatment outcomes for African Americans with HIV

Children hospitalized for pneumonia have similar outcomes with big gun antibiotics or penicillin

Children hospitalized for pneumonia have similar outcomes with big gun antibiotics or penicillin

Genocea commences GEN-004 Phase 1 study to prevent pneumococcus infections

Genocea commences GEN-004 Phase 1 study to prevent pneumococcus infections

New NPS Direct article reveals that vaccinations fight against antibiotic resistance

New NPS Direct article reveals that vaccinations fight against antibiotic resistance

New NPS Direct article reveals that vaccinations fight against antibiotic resistance

New NPS Direct article reveals that vaccinations fight against antibiotic resistance

Griffith University launches new online scholarly journal to fight against pneumonia

Griffith University launches new online scholarly journal to fight against pneumonia

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Urinary pneumococcal antigen testing ‘useful in children’

Urinary pneumococcal antigen testing ‘useful in children’

Inhaled corticosteroids increase pneumonia risk in asthma

Inhaled corticosteroids increase pneumonia risk in asthma

Study finds similar antibody levels among 4 PCV13 immunization schedules

Study finds similar antibody levels among 4 PCV13 immunization schedules

Immunization in developing countries: an interview with Dr. Jos Vandelaer, Chief of Immunization for UNICEF

Immunization in developing countries: an interview with Dr. Jos Vandelaer, Chief of Immunization for UNICEF

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

Pneumococcal vaccine pre-clinical development supported by £0.2 million award from Biomedical Catalyst

Pneumococcal vaccine pre-clinical development supported by £0.2 million award from Biomedical Catalyst

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Vaccine prices and availability: an interview with Kate Elder, Vaccines Policy Advisor for Médecins Sans Frontières's Access Campaign

Vaccine prices and availability: an interview with Kate Elder, Vaccines Policy Advisor for Médecins Sans Frontières's Access Campaign

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.